ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
GlaxoSmithKline AG - Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension
0064001
Infanrix hexaPulver und Suspension zur Herstellung einer Injektionssuspension
J07CA09Diphtherie-Tetanus-Pertussis-Poliomyelitis-Haemophilus-influenzae-B-Hepatitis-B
02.10.2000  
Composition
I) DTPa-HepB-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione. I) et II) corresp. DTPa-HepB-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
Packungsbestandteile
II
 
Suspension injectable 
  
  
BAG: Principe actifConcentr.
Haemagglutinium Filamentosum (B. Pertussis)25 mcg
Haemophilus Influenzae b Polysaccharida (Prp)10 mcg
Pertactinum (B. Pertussis)8 mcg
Toxoidum Diphtheriae30 UI
Toxoidum Pertussis25 mcg
Toxoidum Tetani40 UI
Vaccinum Hepatitidis b (Adnr) Hbsag10 mcg
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)40 UI
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)8 UI
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)32 UI
 
Agents auxilliairesConcentr.
Aluminii Phosphas 
Conjugata cum Toxoido Tetani10 µg
Lactosum 
Polysaccharida Haemophili Influenzae Typus B20752
 
I
 
Suspension injectable 
  
 
Principe actifConcentr.
Haemagglutininum Filamentosum (B. Pertussis)25µg / 0.5ml
Hepatitidis b viri Antigenum Adnr10µg / 0.5ml
Pertactinum (B. Pertussis)8µg / 0.5ml
Toxoidum Diphtheriae30U.I. / 0.5ml
Toxoidum Pertussis25µg / 0.5ml
Toxoidum Tetani40U.I. / 0.5ml
Virus Poliomyelitis Typus 1 Inactivatus (Mahoney)40U.I. / 0.5ml
Virus Poliomyelitis Typus 2 Inactivatus (Mef1)8U.I. / 0.5ml
Virus Poliomyelitis Typus 3 Inactivatus (Saukett)32U.I. / 0.5ml
BAG: Principe actifConcentr.
Haemagglutinium Filamentosum (B. Pertussis)25 mcg
Haemophilus Influenzae b Polysaccharida (Prp)10 mcg
Pertactinum (B. Pertussis)8 mcg
Toxoidum Diphtheriae30 UI
Toxoidum Pertussis25 mcg
Toxoidum Tetani40 UI
Vaccinum Hepatitidis b (Adnr) Hbsag10 mcg
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)40 UI
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)8 UI
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)32 UI
 
Agents auxilliairesConcentr.
Aluminii Hydroxidum Hydricum ad Adsorptionem 
Aluminii Phosphas 
Medium199
Sodium Chlorure 
 
numéro d'emballage Taille des présentationsPEFPPCat.LSHors commerce (MedRef)
003 51.6672.60BLSNon
00410 x 1DDPDDPB Non
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home